Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population

Objective Hydroxychloroquine (HCQ) has been associated with improved survival among patients with systemic lupus erythematosus (SLE) from tertiary referral centers. We aimed to determine the potential impact of HCQ use on the risk of mortality among SLE patients in the general population. Methods We conducted a nested case–control study within an incident SLE cohort from the entire population of British Columbia, Canada. Deceased patients were...